Swayamjeet Satapathy

11PUBLICATIONS
20CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 13, 2026
[177Lu]Lu-PSMA-617 Plus Short-Course Priming With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Single-Arm Phase 2 Trial (Lu-PRIME).

|Jan 07, 2026
68Ga-PSMA-11 PET/CT Versus Conventional Imaging for Response Evaluation in Metastatic Castration-resistant Prostate Cancer: A Single-center Prospective Study.

Komal Preet, Ashwani Sood, Swayamjeet Satapathy

|Sep 29, 2025
Radioiodine Plus Low-Dose Lenvatinib in Radioiodine-Sensitive High-Volume Metastatic Differentiated Thyroid Cancer: A Pilot Study.

Chandra Teja Reddy Singareddy, Chandrasekhar Bal, Swayamjeet Satapathy

|May 25, 2025
Novel framework for response evaluation criteria in grade 1/2 neuroendocrine tumors (RECIN) following [177Lu]Lu-DOTATATE therapy: post-hoc analysis of the phase 2 LuCAP trial.

Swayamjeet Satapathy, Piyush Aggarwal, Ashwani Sood

|May 20, 2025
Safety and Efficacy of Peptide Receptor Radionuclide Therapy in Multiple Endocrine Neoplasia Syndrome: A Single-center Experience.

Piyush Aggarwal, Swayamjeet Satapathy, Gurjeet Kaur

|Mar 11, 2025
PSMA-based Theranostics in Advanced Non-small Cell Lung Cancer: A Hit or a Miss?

Piyush Aggarwal, Anupriya Anwariya, Komalpreet Kaur

Pageof 2

Frequent Collaborators

4 joint publications

Ashwani Sood

3 joint publications

Piyush Aggarwal

3 joint publications

Bhagwant Rai Mittal

2 joint publications

Chandrasekhar Bal